Marginated Neutrophils in the Lungs Effectively Compete for Nanoparticles Targeted to the Endothelium, Serving as a Part of the Reticuloendothelial System

Marco E. Zamora(Translational Therapeutics (United States)), Edward Cantu(California University of Pennsylvania), Tea Shuvaeva(Translational Therapeutics (United States)), Vladimir R. Muzykantov(Translational Therapeutics (United States)), Joseph D. Planer(Pulmonary and Allergy Associates), Kara L. Spiller(Drexel University), Mortimer Poncz, Jarod A. Zepp(Children's Hospital of Philadelphia), Carolann Espy(Translational Therapeutics (United States)), Aditi Murthy(Pulmonary and Allergy Associates), Serena Omo‐Lamai(Translational Therapeutics (United States)), Maria C. Basil(Brigham and Women's Hospital), Sachchidanand Tiwari(Jawaharlal Nehru University), Evguenia Arguiri(Translational Therapeutics (United States)), Jacob W. Myerson(Translational Therapeutics (United States)), Jia Nong(Translational Therapeutics (United States)), Oscar A. Marcos‐Contreras(Translational Therapeutics (United States)), Lubica Rauova(Children's Hospital of Philadelphia), Kartik Bhamidipati(Translational Therapeutics (United States)), Manthan N. Patel(Translational Therapeutics (United States)), Jichuan Wu(University of Pennsylvania), Fatima Chaudhry(Children's Hospital of Philadelphia), Elizabeth D. Hood(Translational Therapeutics (United States)), Zhicheng Wang(Central South University), Jing Liu(Chinese Academy of Sciences), Hyun‐Jun Kim(Children's Hospital of Philadelphia), Laura T. Ferguson(Pulmonary and Allergy Associates), Eno‐Obong Essien(Translational Therapeutics (United States))

ACS Nano

August 6, 2024

Cited by 25

|Nature reviews. Immunology|2015|743

|American Journal of Respiratory and Critical Care Medicine|2013|686

|Molecular Therapy|2008|566

|Science Advances|2020|280

|Molecular Therapy|2021|272

Related Papers